4-heterocyclyl-substituted quinazoline derivatives, processes for their
申请人:Pfizer Inc.
公开号:US05736534A1
公开(公告)日:1998-04-07
This invention relates to certain 4-aminoquinazolines and the pharmaceutically acceptable salts and stereoisomers thereof, the formula whereof are described herein. The compounds are useful for the treatment of hyperproliferative diseases, particularly as anti-cancer agents.
The invention relates to compounds of the formula
1
and to pharmaceutically acceptable salts thereof, wherein R
1
, R
2
and Z are as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of formula I and to methods of using said compounds in the treatment of hyperproliferative diseases such as cancer.